OVID
Ovid Therapeutics Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
No thesis.
Ovid Therapeutics Inc.
2.54
Linked news
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Jupiter TopcoJupiter Topco | $55.9M | 14.11% | — | |
| 2 | Eventide Asset ManagementEventide | $31.8M | 8.02% | +19.11% | |
| 3 | BlackRockBlackRockindex-like | $29.1M | 7.35% | +605.90% | |
| 4 | RA Capital ManagementRA Capital Management | $28.2M | 7.13% | −1.99% | |
| 5 | Affinity Asset AdvisorsAffinity Asset | $27.3M | 6.89% | −4.62% | |
| 6 | State StreetState Streetindex-like | $21.3M | 5.36% | +1418.55% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $20.9M | 5.27% | +47.58% | |
| 8 | ADAR1 Capital ManagementADAR1 | $20.0M | 5.04% | +63.23% | |
| 9 | Balyasny Asset ManagementBalyasny | $18.1M | 4.56% | +21.43% | |
| 10 | Adage Capital Partners GPAdage Capital Partners GP | $16.6M | 4.19% | 0.00% | |
| 11 | Federated InvestorsFederated Investors | $16.0M | 4.04% | +66.67% | |
| 12 | BraidwellBraidwell | $15.9M | 4.02% | new | |
| 13 | Geode Capital ManagementGeodeindex-like | $11.0M | 2.77% | +208.98% | |
| 14 | Silverarc Capital ManagementSilverarc | $8.3M | 2.11% | +210.11% | |
| 15 | StemPoint CapitalStemPoint Capital | $6.5M | 1.64% | new | |
| 16 | Ikarian CapitalIkarian Capital | $6.1M | 1.54% | −21.59% | |
| 17 | Point72 Asset ManagementPoint72 | $5.2M | 1.32% | +47.34% | |
| 18 | Sphera Funds ManagementSphera Funds | $3.6M | 0.92% | −16.63% | |
| 19 | Northern TrustNorthern Trustindex-like | $3.4M | 0.85% | +389.06% | |
| 20 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $3.1M | 0.77% | +64.55% | |
| 21 | Propel Bio ManagementPropel Bio | $3.0M | 0.76% | +21.06% | |
| 22 | Rosalind AdvisorsRosalind | $3.0M | 0.75% | 0.00% | |
| 23 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $2.8M | 0.70% | new | |
| 24 | Sio Capital ManagementSio | $2.7M | 0.68% | −19.73% | |
| 25 | Ensign Peak AdvisorsEnsign Peak | $2.7M | 0.67% | new |
131 managers report $396.2M of Ovid Therapeutics on form 13F for the quarter ended Jun 30 '26. 14 of them hold 80% of it; Jupiter Topco is largest at 14.11%.
Expected move
Inputsstraddle ±33.5%
spot 2.54exp Nov 20ATM strike 2.5ATM straddle 1.00IV 209%